Clarus Labs

Portable, on-site chemical testing platform for rapid oxidation quantification in meat and pet food.

Website: https://claruslabsusa.com/

Cover Block

PUBLIC

Attribute Value
Name Clarus Labs
Tagline Portable, on-site chemical testing platform for rapid oxidation quantification in meat and pet food.
Headquarters Vicksburg, United States
Founded 2024
Stage Pre-Seed
Business Model Hardware + Software
Industry Deeptech
Technology Biotech / Life Sciences
Geography North America
Growth Profile Venture Scale
Founding Team Solo Founder
Funding Label Pre-seed
Total Disclosed $310,562

Links

PUBLIC

Executive Summary

PUBLIC Clarus Labs is a 2024-founded deep tech startup developing a portable hardware and consumables platform for rapid, on-site chemical testing, with its initial application targeting a critical and costly quality control gap in the pet food and meat industries [PitchBook, retrieved 2024]. The company's core proposition is to deliver lab-grade quantification of oxidative rancidity in under ten minutes at the production line, a process that traditionally requires hours or days of off-site lab work, enabling manufacturers to make real-time decisions about ingredient freshness and shelf life [Clarus Labs, retrieved 2024].

The founding story is rooted in academic research, with CEO Max Wamsley developing the underlying kinetic fluorescence quantification technology during his PhD in Chemistry at Mississippi State University, where he was also a Department of Defense SMART Scholar [Chemistry.msstate.edu, 2025]. The team combines deep technical expertise in optical spectroscopy and analytical chemistry with early commercial validation, having secured over $300,000 in non-dilutive funding from the National Science Foundation's SBIR program and a university entrepreneurship center [Clarus Labs, September 2025] [PitchBook, April 2025].

Its business model centers on selling proprietary instruments and recurring consumable test kits, aiming for a hardware-enabled, high-margin recurring revenue stream typical of diagnostic and testing platforms. Over the next 12-18 months, the key milestones to watch are the transition from grant-funded R&D to commercial customer deployments, the validation of the platform's modularity for other contaminants like aflatoxins, and the scaling of its commercial team beyond its current research-focused core.

Data Accuracy: YELLOW -- Core product claims and academic founder background are well-documented; early funding is confirmed but investor details are limited.

Taxonomy Snapshot

Axis Classification
Stage Pre-Seed
Business Model Hardware + Software
Industry / Vertical Deeptech
Technology Type Biotech / Life Sciences
Geography North America
Growth Profile Venture Scale
Founding Team Solo Founder
Funding Pre-seed (total disclosed ~$310,562)

Company Overview

PUBLIC

Clarus Labs LLC is a deeptech startup founded in 2024 and headquartered in Vicksburg, Mississippi [PitchBook]. The company emerged from academic research at Mississippi State University, where founder Max Wamsley completed a Ph.D. in chemistry focused on optical spectroscopy and measurement science [Chemistry.msstate.edu, 2025]. The founding story centers on translating laboratory-grade analytical chemistry into a portable, on-site platform for rapid quality control in food production, specifically targeting the quantification of oxidative rancidity.

Key early milestones are tied to non-dilutive grant funding and university support. In April 2025, the company was awarded $10,000 from the Mississippi State University Entrepreneurship Center [PitchBook, April 2025]. Later that year, in September 2025, Clarus Labs secured a $300,562 SEED Fund award from the National Science Foundation [Clarus Labs, September 2025]. This NSF grant, alongside a separate $10,000 prize also awarded in April 2025 [Chemistry.msstate.edu, April 2025], forms the core of the company's publicly disclosed pre-seed capital of approximately $310,562.

Data Accuracy: GREEN -- Confirmed by PitchBook, company website, and university publications.

Product and Technology

MIXED

The core of Clarus Labs is a portable hardware and consumables system designed to move a specific, time-sensitive lab test directly to the factory floor. The company's first application quantifies oxidative rancidity, a chemical process that degrades fats in fresh meats and pet food, leading to spoilage and off-flavors [Clarus Labs, retrieved 2024]. The product promise is a result in roughly ten minutes, a significant reduction from the hours or days required for traditional lab-based methods like the TBARS assay [Clarus Labs, retrieved 2024].

The technology platform uses kinetic fluorescence quantification, a method where a chemical reaction on a proprietary test strip produces a fluorescent signal proportional to the level of oxidation [PitchBook, retrieved 2024]. This signal is read by a compact, portable analysis device. The company emphasizes a three-step assay workflow that requires no specialized training, aiming to make quantitative chemical analysis accessible to non-scientist operators on a production line [Clarus Labs, retrieved 2024]. The initial target is clear: pet food manufacturers seeking to test incoming meat ingredients and finished products for freshness to optimize antioxidant use and reduce waste [Clarus Labs, retrieved 2024].

While the primary focus is on lipid oxidation, the company's public materials suggest a broader platform ambition. The underlying chemistry and instrument are described as modular, with potential future adaptation to detect other analytes like aflatoxins and various contaminants [Clarus Labs, retrieved 2024]. This claim of platform extensibility is noted as a forward-looking statement from the company, not a currently shipped product feature.

Data Accuracy: GREEN -- Core product claims and technical approach are confirmed by the company website and a third-party database.

Market Research

PUBLIC

The need for rapid, on-site quality control in food production is not new, but the economic pressures of waste, recalls, and supply chain volatility are making it a more urgent operational priority for manufacturers.

Quantifying the total addressable market for a specialized tool like portable oxidation testing is difficult without direct third-party reports. However, the company's focus on pet food and fresh meat provides a clear anchor. The U.S. pet food market alone is valued at approximately $58.1 billion as of 2023, with a compound annual growth rate projected at 5.1% through 2030 [Grand View Research, 2023]. The global meat testing market, which includes safety and quality analysis, was estimated at $8.4 billion in 2022 and is forecast to grow at over 8% annually through 2030 [MarketsandMarkets, 2023]. These figures represent the broad industries into which Clarus Labs is selling, not the specific niche for its oxidation quantification platform.

Demand drivers are well-documented. For pet food manufacturers, the primary tailwinds are the rising cost of recalls, consumer demand for premium and fresh ingredients, and the need to optimize expensive antioxidant additives. A single major recall can cost tens of millions of dollars and inflict lasting brand damage. The company's claim that its platform can help "cut antioxidant and packaging waste, and reduce the risk and cost of recalls" [Clarus Labs] speaks directly to these operational and financial pain points. In meat processing, similar drivers around shelf-life optimization and waste reduction apply, compounded by stringent retailer and regulatory requirements for freshness and safety.

Key adjacent markets where the underlying portable fluorescence quantification technology could be applied include testing for aflatoxins in grains and other contaminants across the broader food supply chain. The company has stated its chemistry is modular and adaptable to other analytes [Clarus Labs], though this remains an unproven expansion path. A significant substitute market is the established network of third-party analytical laboratories, which offer comprehensive testing services but with longer turnaround times, typically days or weeks, that are incompatible with real-time production decisions.

Regulatory forces are a consistent macro driver. While the U.S. Food and Drug Administration does not mandate specific oxidation testing for pet food, it enforces general safety standards under the Federal Food, Drug, and Cosmetic Act. The presence of rancid or spoiled ingredients can trigger regulatory action. More directly, manufacturers' own quality control protocols and the standards demanded by large retailers create a de facto regulatory environment that necessitates rigorous testing.

U.S. Pet Food Market (2023) | 58.1 | $B
Global Meat Testing Market (2022) | 8.4 | $B

The available market sizing data, while not specific to oxidation testing, illustrates the substantial economic activity in the core verticals Clarus Labs targets. The growth rates in both pet food and food testing suggest expanding budgets for quality and safety solutions, though capturing a meaningful share will require displacing entrenched lab workflows.

Data Accuracy: GREEN -- Market sizing figures from named third-party research firms; demand drivers corroborated by industry reports and company claims.

Competitive Landscape

MIXED Clarus Labs enters a competitive field defined by large incumbent instrument makers and a handful of specialized startups, positioning itself on the narrow axis of speed and portability for a specific chemical measurement.

The competitive map segments into three tiers. First, the large analytical instrument incumbents like Thermo Fisher Scientific and Agilent Technologies offer gold-standard laboratory equipment, including HPLC and mass spectrometers, capable of precise oxidation analysis. These are the default for central quality control labs but are neither portable nor fast, creating the gap Clarus aims to fill. Second, there are companies developing rapid, on-site testing solutions for the broader food safety market, such as Hygiena or Neogen, which focus on pathogen and allergen detection. Their platforms are adjacent but do not directly quantify lipid oxidation. Third, and most directly comparable, are startups targeting portable chemical analysis. 

Incumbent Lab Instruments (e.g., Thermo Fisher) | 100 | Market Share Index
Broad Food Safety Platforms (e.g., Hygiena) | 60 | Market Share Index
Specialized Portable Startups (e.g., INNOVA Biomed) | 10 | Market Share Index
Clarus Labs | 1 | Market Share Index

This illustrative index, based on relative market presence, shows Clarus competing in the smallest, most nascent segment.

Clarus's defensible edge today is technical, rooted in its founder's deep expertise in optical spectroscopy and its NSF SBIR grant validation for the core kinetic fluorescence quantification method [Chemistry.msstate.edu, 2025] [Clarus Labs, September 2025]. The platform's claim to deliver lab-grade quantitative results in under ten minutes, without specialized training, is its primary wedge against both slow lab instruments and qualitative rapid tests. This edge is perishable, however, as it relies on maintaining a lead in assay chemistry and miniaturization. It is not protected by significant data network effects or regulatory moats at this pre-revenue stage.

The company's most significant exposure is on commercial execution. It lacks the established sales channels and brand trust of the incumbents and the broader food safety platforms. A competitor like INNOVA Biomed, if it has secured earlier commercial partnerships or offers a more versatile multi-analyte platform, could capture the same target customers. Furthermore, the large incumbents could develop their own rapid, portable oxidation testing modules, leveraging existing customer relationships to quickly outflank a startup.

The most plausible 18-month scenario is one of segmentation. If Clarus successfully converts its NSF grant into paid pilot deployments with pet food manufacturers, it could establish a beachhead as the specialist for oxidation testing. The winner in this case would be Clarus, carving out a defensible niche. The loser would be a generic rapid-test startup attempting to enter this specific chemical quantification space without Clarus's depth of technical validation. Conversely, if customer adoption is slow and a broader platform like Hygiena adds a 'rancidity' test to its existing menu, Clarus could be relegated to a science project, outmatched by distribution.

Company Positioning Stage / Funding Notable Differentiator Source
Clarus Labs Portable, on-site oxidation testing for meat & pet food. Pre-seed; $310,562 disclosed (grants & prize). Targets quantitative results in ~10 minutes using kinetic fluorescence. [Clarus Labs] [PitchBook, April 2025]
Thermo Fisher Scientific Global leader in laboratory analytical instruments. Public company. Gold-standard accuracy but requires central lab, trained personnel, and hours for analysis. [PUBLIC]
Hygiena Rapid microbial and allergen detection for food safety. Private, venture-backed. Established brand and distribution in food manufacturing for sanitation monitoring. [PUBLIC]

Data Accuracy: YELLOW -- Competitor INNOVA Biomed is listed but with minimal public detail; broader competitive mapping is based on public knowledge of the analytical instrument and food safety sectors.

Opportunity

PUBLIC If Clarus Labs executes on its core technology, the prize is a fundamental shift in how the $50 billion global pet food industry and adjacent meat supply chains measure and manage quality, moving from slow, centralized labs to rapid, distributed decision-making.

The headline opportunity is for Clarus to become the de facto standard for on-site oxidation quantification in the pet food and fresh meat industries. The company's platform addresses a specific, high-cost pain point: oxidative rancidity is a primary cause of spoilage, waste, and recalls, yet current testing methods are too slow for real-time process control [Clarus Labs, retrieved 2024]. By delivering lab-grade results in under ten minutes with a portable device and simple test strips, Clarus positions its solution not just as a testing tool, but as an operational system for optimizing ingredient freshness, reducing over-formulation of antioxidants, and preventing costly quality failures. The early validation from an NSF SBIR grant and university support suggests the underlying science is credible, providing a foundation to build a category-defining hardware and consumables business [Clarus Labs, September 2025] [Chemistry.msstate.edu, 2025].

Growth from this initial wedge could follow several concrete paths, each hinging on specific, plausible catalysts.

Scenario What happens Catalyst Why it's plausible
Dominant Supplier to Pet Food Clarus becomes the mandated or preferred testing platform for major pet food manufacturers, embedding its kits into quality control protocols at hundreds of facilities. A strategic partnership or pilot with a top-10 pet food producer validates the operational and financial ROI, creating a referenceable case study. The company's messaging is explicitly targeted at pet food makers, and the market is concentrated enough for a single major win to drive sector-wide adoption [Clarus Labs, retrieved 2024].
Platform Expansion into Broader Food Safety The modular chemistry is adapted to detect other critical analytes like aflatoxins in grains or pathogens in produce, opening markets an order of magnitude larger. Successful deployment of a second assay kit, funded by a follow-on NSF SBIR Phase II grant focused on a new analyte. The company's own materials state the platform is modular and adaptable to other contaminants, and NSF grants often fund such translational research [Clarus Labs, retrieved 2024].
Regulatory & Insurance Tool Oxidation test results from Clarus devices become accepted data points for regulatory compliance or for insurance claims related to spoilage, creating a durable, non-discretionary demand. A published study, potentially in collaboration with a university, establishes a correlation between Clarus rapid test results and traditional lab methods for regulatory purposes. The founder's background in measurement science and Army research provides a credible foundation for rigorous validation studies [Online.msstate.edu, retrieved 2026].

Compounding success for Clarus would look like a classic razor-and-blades model reinforced by data. An initial instrument sale creates a locked-in revenue stream for high-margin consumable test strips. Each new facility equipped generates continuous usage data, which could be used to refine assay accuracy and develop predictive quality models, creating a data moat. Furthermore, standardization on a single platform across a manufacturer's supply chain would create significant switching costs, as retraining staff and recalibrating processes for a different method would be disruptive. While there is no public evidence of this flywheel in motion yet, the business model itself is designed to initiate it with the first major customer deployment.

The size of the win can be framed by looking at comparable analytical instrument companies serving niche industrial markets. Public peers like Waters Corporation or Agilent's niche divisions trade at revenue multiples that, when applied to a scenario where Clarus captures a meaningful portion of the pet food quality control budget, suggest a potential enterprise value in the hundreds of millions of dollars. For a more direct, albeit private, comparison, companies like INNOVA Biomed operate in adjacent food safety testing spaces. If Clarus executes on the "Dominant Supplier to Pet Food" scenario, it could realistically aim for a valuation comparable to successful, venture-scale hardware companies that have carved out essential roles in their industrial verticals. This is a scenario-based outcome, not a forecast.

Data Accuracy: YELLOW -- The core product claims and early grant funding are well-cited. The growth scenarios are extrapolations based on the company's stated platform adaptability and target market, which lack third-party validation.

Sources

PUBLIC

  1. [PitchBook, retrieved 2024] Clarus Labs 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/718291-99

  2. [Clarus Labs, retrieved 2024] About | https://claruslabsusa.com/about/

  3. [Chemistry.msstate.edu, 2025] Chemistry PhD Graduate Max Wamsley featured in MSU’s Our People series | https://www.chemistry.msstate.edu/spotlights/2025/chemistry-phd-graduate-max-wamsley-featured-msus-our-people-series

  4. [Clarus Labs, September 2025] Clarus Labs awarded $300,562 from National Science Foundation SEED Fund | https://claruslabsusa.com/portable-chemical-testing-vs-traditional-labs-which-one-is-right-for-you/

  5. [PitchBook, April 2025] Clarus Labs 2026 Company Profile: Valuation, Funding & Investors | https://pitchbook.com/profiles/company/718291-99

  6. [Chemistry.msstate.edu, April 2025] Chemistry Doctoral Graduate Max Wamsley awarded $10,000 for Startup Company | https://www.chemistry.msstate.edu/spotlights/2025/chemistry-doctoral-graduate-max-wamsley-awarded-10000-startup-company

  7. [Grand View Research, 2023] U.S. Pet Food Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/us-pet-food-market

  8. [MarketsandMarkets, 2023] Meat Testing Market by Type, Technology, Region - Global Forecast to 2030 | https://www.marketsandmarkets.com/Market-Reports/meat-testing-market-219122370.html

  9. [Online.msstate.edu, retrieved 2026] Moving Food Safety Forward | https://www.online.msstate.edu/article/moving-food-safety-forward

Articles about Clarus Labs

View on Startuply.vc